Telbermin
- Generic Name
- Telbermin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 205887-54-3
- Unique Ingredient Identifier
- 22G76ZW50X
- Background
Telbermin has been used in trials studying the treatment of Foot Ulcer, Foot Ulcer, Diabetic, and Amyotrophic Lateral Sclerosis.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT00351767
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath